Deal could be worth $947 million
Working on new tools to self-manage disease
First country in the world to offer jab routinely
131.5 million sufferers by 2050
Starts Phase III programme for oral semaglutide
Will help tailor treatment
Registers of hospitality to be set up
Warnings of an epidemic could have been exaggerated
Also nabs new R&D chief from Roche
One in four prescriptions - 10 million - are unnecessary
Deal could be worth $326 million to troubled US biotech
Exp. Medical Reps and trainees. KAMs; eDetailing Reps Nationwide Opportunities
Click here to apply now!
2 x Respiratory Med Rep!
Click here to apply!
Nurse Advisor Roles
Click here to apply now
Find your next position today!
Click here to apply
Recruiting for various roles across the UK
Click here now!
No running polls, please check backsoon.
Increase your knowledge. Browse the Pf Archive.
Read Pf now
Looking to make a move? Find your next job here.
click here to createan account
Need career advice? Visit our Career Centre.